Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries

Abstract

Analyses of efficacy of rituximab in real clinical practice of European registries. Pooled data of 1 year treatment in 10 countries.Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed

Keywords

• PLACEBO-CONTROLLED TRIAL
• DOUBLE-BLIND
• INADEQUATE RESPONSE
• B-CELLS
• EFFICACY
• AGENTS
• METHOTREXATE
• THERAPY
• MULTICENTER
• INHIBITION